Stoke Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Stoke Therapeutics, Inc.
CIK #0001623526
EDGAR Form CIK 2011 - 2025
10-K [0001623526]
10-Q [0001623526]
3 [0001623526]
4 [0001623526]
8-K [0001623526]
D [0001623526]
SC 13D [0001623526]
SC 13G [0001623526]
Form 13D/13G Filer Form 13D/13G Subject Filed
FMR LLC Stoke Therapeutics Inc [2025-06-06]
BlackRock Portfolio Management LLC Stoke Therapeutics Inc [2025-04-15]
Baker Bros Advisors LP Stoke Therapeutics Inc [2024-11-14]
BlackRock Inc Stoke Therapeutics Inc [2024-07-08]
Cowen Financial Products LLC Stoke Therapeutics Inc [2024-02-26]
Lynx1 Capital Management LP Stoke Therapeutics Inc [2023-11-06]
Morgan Stanley Stoke Therapeutics Inc [2023-02-10]
Vanguard Group Inc Stoke Therapeutics Inc [2022-02-10]
Cowen Financial Products LLC Stoke Therapeutics Inc [2022-01-24]
Skorpios Trust Stoke Therapeutics Inc [2021-06-30]
View All
Form 3/4/5 Subject 2011 - 2025
Stoke Therapeutics, Inc.
Kaye Edward M. MD
Allan Jonathan
Ticho Barry
Levin Arthur A
Hoitt Jason
Montrago Trustees Ltd
Blue Horizon Enterprise Ltd
Skorpios Trust
Ezbon International Ltd
View All
Terms | Privacy | Guide
tony@aum13f.com